Stemcells, Inc.

Calculating rank

USPTO Granted Patents = 5

% Expired Patents = 40.0

EPO Patents = 1

Trademarks = 1

Forward Citations = 99

Loading Chart...

5 inventors (with patents filed for the assignee):

Eric Lagasse (3 out of 6 patents)

Timothy Austin (3 out of 3 patents)

Nobuko Uchida (2 out of 10 patents)

4. Irving L Weissman (1 out of 149 patents)

5. David W Buck (1 out of 16 patents)

5 patents: Sort by Forward Citations

1. 8283164 - Liver engrafting cells, assays, and uses thereof (2012-10-09),

2. 7811818 - Human liver engrafting cells isolated from adult liver tissue (2010-10-12),

3. 7211404 - Liver engrafting cells, assays, and uses thereof (2007-05-01),

4. 6468794 - Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations (2002-10-22),

5. 6238922 - Use of collagenase in the preparation of neural stem cell cultures (2001-05-29),

Company Overview

StemCells, Inc. is a biotechnology company focused on the research, development, and commercialization of novel stem cell therapies. The company harnesses the power of stem cells to create innovative treatments for a variety of diseases and medical conditions. StemCells, Inc. is dedicated to advancing regenerative medicine and improving patient outcomes through cutting-edge research and development.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

5 Patents

#49 in Newark, CA

#12,079 in California

#51,669 in US

Newark, CA, United States of America

Stemcells, Inc.

Forward Citations = 99

5 inventors:

Eric Lagasse (3 out of 6 patents)

Timothy Austin (3 out of 3 patents)

Nobuko Uchida (2 out of 10 patents)

4. Irving L Weissman (1 out of 149 patents)

5. David W Buck (1 out of 16 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Stemcells, Inc.. Retrieved from https://idiyas.com/company/stemcells

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]